Globalization

WuXi AppTec seeks to expand in US with ongoing closure of Wuhan facility

20-Feb-2020 By Nick Taylor

WuXi AppTec looks to US sites to offset capacity lost due to ongoing closure of Chinese facility due to the coronavirus.

‘You get what you pay for’ on API quality

19-Feb-2020 By Ben Hargreaves

As C2 Pharma works to expand its API portfolio, its CEO states that there is ‘no short game’ on API quality.

Sun Pharma blames 'speculative buying' on coronavirus-related price hikes

17-Feb-2020 By Nick Taylor

Sun Pharma argues rising ingredient and finished product prices are unjustified, blames ‘speculative buying’ for trend.

Industry demands ‘closest possible relationship’ between UK and EU

13-Feb-2020 By Ben Hargreaves

European industry organizations call for trade negotiations between the UK and the EU to begin with a mutual recognition agreement.

Cardinal tips API supply chain to weather impact of coronavirus

10-Feb-2020 By Nick Taylor

Cardinal predicts API industry ‘should be able to work through’ coronavirus outbreak despite exposure to China.

Pfizer's CDMO unit drives growth at hospital business

03-Feb-2020 By Nick Taylor

Pfizer attributes performance of contract manufacturing unit as driver of growth at hospital business.

AZ and Takeda outline sustainability plans

30-Jan-2020 By Ben Hargreaves

Both major pharma companies have used January to announce programs to reduce their climate impact.

Accenture’s data sharing platform climbs on Google Cloud

30-Jan-2020 By Vassia Barba

Accenture’s Intient platform for clinical data management will use Google Cloud as a cloud technology provider.

Could the coronavirus impact supply of APIs?

29-Jan-2020 By Ben Hargreaves

First quarter supplies of APIs are expected to be affected by the recent outbreak of coronavirus, according to survey.

LOMÉ INITIATIVE SIGNING

Demanding quality: WHO on securing a vulnerable supply chain

23-Jan-2020 By Vassia Barba

As African countries look to secure their supply chains, head of the WHO’s team on fighting falsified and substandard medicine speaks about how to ‘demand quality’.

Boom in number of UK cell and gene therapy clinical trials

22-Jan-2020 By Ben Hargreaves

Year-on-year, the number of trials for advanced therapeutics has doubled, meaning that the UK now represents 12% of all global clinical trials in the area.

Surging local demand drives 24% growth of Korean contract service sector

15-Jan-2020 By Nick Taylor

South Korean contract service market grows 24% as local biopharma companies step up spending.

ClinOne enters EU with first office in the UK

06-Jan-2020 By Vassia Barba

ClinOne looks to further support its clinical trial partners in the European Union by opening its first office in the region, located in London, UK.

Sanofi to 'optimize' CMOs to drive down spending

18-Dec-2019 By Nick Taylor

Sanofi plans “optimization of CMOs and suppliers” as new CEO targets €2bn in savings by 2022.

Kyowa Kirin creates quality unit with direct line to CEO

05-Dec-2019 By Nick Taylor

Kyowa Kirin reorganizes to create quality division that reports directly to CEO Masashi Miyamoto.